Clinical Trial

Post Market Clinical Follow up Evaluating the Performance and Safety of Juläine(TM) on Nasolabial Fold Wrinkles

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this post marketing study is to verify clincal performance and safety of CE-marked device Juläine. The main objective is to evaluate device performance when used as intended for augmentation of shallow to deep nasolabial folds. Participants will: Receive 3 rounds of treatment and will be followed up for a total of 2 years.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-06-23; most recent amendment 2026-04-27.
Status change: Recruiting → Active, Not Recruiting 2025-08-19
Status change: Not Yet Recruiting → Recruiting 2024-08-23
Trial Details
NCT Number NCT06471933
Lead Sponsor Nordberg Medical AB
Conditions Nasolabial Fold
Enrollment 59 participants
Start Date 2024-07-24
Primary Completion 2026-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-01